Disc Medicine IRON
NASDAQ IRON
$79.23 -0.14 (-0.18%)
As of: Sep 4, 2026 · 3:59 PM EDT

Disc Medicine (IRON) Non-Current Assets (2020 - 2026)

Disc Medicine (IRON) posted quarterly Non-Current Assets of $2.3 million for Q2 2026, down 33.41% year-over-year from $3.5 million in Q2 2025, and down 16.24% quarter-over-quarter from $2.8 million in Q1 2026.

Analysis

Disc Medicine (IRON) Non-Current Assets (2020 - 2026) Analysis & Trends

Disc Medicine (IRON) has reported Non-Current Assets for 7 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Non-Current Assets fell 33.41% year-over-year to $2.3 million; the TTM figure through Jun 2026 stood at $11.3 million (down 7.72% YoY), while the FY2025 annual figure was $3.0 million, down 5.6% from the prior year.
  • Non-Current Assets retreated to $2.3 million in Q2 2026 per IRON's latest filing, from $2.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $3.7 million in Q1 2025 and bottomed at $204000.0 in Q2 2022.
  • Historically, Non-Current Assets has averaged $2.2 million across 5 years, with a median of $2.3 million in 2023.
  • Annual changes were most pronounced in 2022 — Non-Current Assets plunged 81.64% — and 2023, when it soared 1096.57%.
  • Disc Medicine's Non-Current Assets stood at $1.7 million in 2022, then jumped by 36.17% to $2.3 million in 2023, then surged by 35.3% to $3.2 million in 2024, then slipped by 5.6% to $3.0 million in 2025, then dropped by 22.51% to $2.3 million in 2026.
  • Business Quant data shows IRON's Non-Current Assets at $2.3 million in Q2 2026, $2.8 million in Q1 2026, and $3.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.15 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 294.93 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.96 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 938.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 18.06 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 468.65 Mn
10 Disc Medicine 3.06 Bn 3.06 Bn - 2.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.31 Mn
Mar 31, 2026 2.76 Mn
Dec 31, 2025 2.98 Mn
Sep 30, 2025 3.29 Mn
Jun 30, 2025 3.47 Mn
Mar 31, 2025 3.67 Mn
Dec 31, 2024 3.16 Mn
Sep 30, 2024 1.99 Mn
Jun 30, 2024 1.98 Mn
Mar 31, 2024 2.23 Mn
Dec 31, 2023 2.33 Mn
Sep 30, 2023 2.23 Mn
Jun 30, 2023 2.44 Mn
Mar 31, 2023 1.64 Mn
Dec 31, 2022 1.71 Mn
Sep 30, 2022 1.37 Mn
Jun 30, 2022 204,000.00
Mar 31, 2022 217,000.00
Dec 31, 2021 1.93 Mn
Sep 30, 2021 735,000.00